328 related articles for article (PubMed ID: 33516338)
41. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
42. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
[TBL] [Abstract][Full Text] [Related]
43. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study.
Savinkina A; Bilinski A; Fitzpatrick M; Paltiel AD; Rizvi Z; Salomon J; Thornhill T; Gonsalves G
BMJ Open; 2022 Sep; 12(9):e061752. PubMed ID: 36100306
[TBL] [Abstract][Full Text] [Related]
44. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.
GBD Diarrhoeal Diseases Collaborators
Lancet Infect Dis; 2017 Sep; 17(9):909-948. PubMed ID: 28579426
[TBL] [Abstract][Full Text] [Related]
45. Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study.
Anderson JD; Bagamian KH; Pecenka CJ; Muhib F; Puett CA; Hausdorff WP; Scheele S
Lancet Glob Health; 2023 Jun; 11(6):e880-e891. PubMed ID: 37202023
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of rotavirus vaccination in Mozambique.
Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F
Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279
[TBL] [Abstract][Full Text] [Related]
47. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
[TBL] [Abstract][Full Text] [Related]
48. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
[TBL] [Abstract][Full Text] [Related]
49. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
[TBL] [Abstract][Full Text] [Related]
50. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
51. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
Miller MA; McCann L
Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
[TBL] [Abstract][Full Text] [Related]
52. Mortality by cause for eight regions of the world: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9061):1269-76. PubMed ID: 9142060
[TBL] [Abstract][Full Text] [Related]
53. Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality.
Kaufmann SHE
Hum Vaccin Immunother; 2019; 15(11):2660-2665. PubMed ID: 30973039
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
[TBL] [Abstract][Full Text] [Related]
55. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.
Chang AY; Riumallo-Herl C; Perales NA; Clark S; Clark A; Constenla D; Garske T; Jackson ML; Jean K; Jit M; Jones EO; Li X; Suraratdecha C; Bullock O; Johnson H; Brenzel L; Verguet S
Health Aff (Millwood); 2018 Feb; 37(2):316-324. PubMed ID: 29401021
[TBL] [Abstract][Full Text] [Related]
56. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
[TBL] [Abstract][Full Text] [Related]
57. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
[TBL] [Abstract][Full Text] [Related]
58. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
Shattock AJ; Johnson HC; Sim SY; Carter A; Lambach P; Hutubessy RCW; Thompson KM; Badizadegan K; Lambert B; Ferrari MJ; Jit M; Fu H; Silal SP; Hounsell RA; White RG; Mosser JF; Gaythorpe KAM; Trotter CL; Lindstrand A; O'Brien KL; Bar-Zeev N
Lancet; 2024 May; 403(10441):2307-2316. PubMed ID: 38705159
[TBL] [Abstract][Full Text] [Related]
59. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
